Skip to content

Effect of ICE guidance in combination with Marshall Ethanol Infusion on mitral isthmus line block

Effect of ICE guidance in combination with Marshall Ethanol Infusion on mitral isthmus line block

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081604
Enrollment
Unknown
Registered
2024-03-06
Start date
2024-03-06
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Case series:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18 -80 years old. (2) Patients with non-valvular atrial fibrillation who were treated in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine and underwent catheter ablation for the first time. (3) Patients with persistent atrial fibrillation have atrial fibrillation lasting more than or equal to 3 months and less than or equal to 3 years. (4) Comply with the indications for catheter ablation of atrial fibrillation specified in China's 2023 Chinese guidelines for the diagnosis and treatment of atrial fibrillation. (5) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Thrombosis or mass in the heart chamber. (2) Atrial fibrillation secondary to obvious reversible causes (including but not limited to hyperthyroidism/hypokalemia, etc.). (3) Clearly diagnosed cardiomyopathy (including but not limited to hypertrophic cardiomyopathy, dilated cardiomyopathy, etc.). (4) There are contraindications to the use of oral anticoagulant drugs. (5) Life expectancy is less than 1 year (such as advanced malignant tumors, advanced kidney disease, etc.). (6) History of heart-related surgery (such as coronary artery bypass/stent implantation/valve replacement, etc.). (7) Severe cardiac or macrovascular malformation. (8) Vulnerable groups, such as people with mental illness, cognitive impairment, critically ill patients, pregnant women, etc.

Design outcomes

Primary

MeasureTime frame
The success rate of mitral isthmus line block;

Secondary

MeasureTime frame
Left atrial voltage;Ablation time;

Countries

China

Contacts

Public ContactChenyang Jiang

Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

cyjiang@zju.edu.cn+86 138 5719 0051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026